David Nunes is a Gastroenterology physician affiliated with Boston Medical Center. OpenAlex indexes 85 publications with 3,571 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany St
Shaprio 6b
Boston, MA 021182905
Telephone
617-638-6525Provider last certified this registry record 30 Jan 2020.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
55.7%Osmotic Laxative28.2%Gavilyte-G62%Peg-3350 And Electrolytes38%Part D≥72 patientsProton pump inhibitor10.4%Omeprazole56%Pantoprazole Sodium44%Part D<11 patients+ 5 more classes in this area
Anti-infectives
25.8%Nucleoside and nucleotide reverse transcriptase inhibitors20.2%Vemlidy100%Part D≥13 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor5.5%Entecavir100%Part D<11 patientsCardiovascular
15.9%Beta blocker12.5%Carvedilol100%Part D≥13 patientsCalcium channel blocker3.4%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1995–1999 per NIH RePORTER. The latest:
- MUCIN AND TREFOIL PROTEINS IN GALLSTONE PATHOGENESIS
Boston Health and Hospitals Department
FY1997K08DK002327
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer
Therapeutic Advances in Medical Oncology
2023 - Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
The Lancet Regional Health - Europe
2022 - Colonic Epithelial Angiotensin-Converting Enzyme 2 (ACE2) Expression in Blacks and Whites: Potential Implications for Pathogenesis Covid-19 Racial Disparities
Journal of Racial and Ethnic Health Disparities
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Sushrut Waikar, MD
Boston Medical Center
Mahmoud Abdelnabi, MD
Boston Medical Center
Carlos Kase, MD
Boston Medical Center
Stephanie Lee, MD, PhD
Boston Medical Center
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”